Your browser doesn't support javascript.
loading
The intrinsic substrate specificity of the human tyrosine kinome.
Yaron-Barir, Tomer M; Joughin, Brian A; Huntsman, Emily M; Kerelsky, Alexander; Cizin, Daniel M; Cohen, Benjamin M; Regev, Amit; Song, Junho; Vasan, Neil; Lin, Ting-Yu; Orozco, Jose M; Schoenherr, Christina; Sagum, Cari; Bedford, Mark T; Wynn, R Max; Tso, Shih-Chia; Chuang, David T; Li, Lei; Li, Shawn S-C; Creixell, Pau; Krismer, Konstantin; Takegami, Mina; Lee, Harin; Zhang, Bin; Lu, Jingyi; Cossentino, Ian; Landry, Sean D; Uduman, Mohamed; Blenis, John; Elemento, Olivier; Frame, Margaret C; Hornbeck, Peter V; Cantley, Lewis C; Turk, Benjamin E; Yaffe, Michael B; Johnson, Jared L.
Afiliación
  • Yaron-Barir TM; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Joughin BA; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Huntsman EM; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Kerelsky A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Cizin DM; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Cohen BM; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Regev A; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Song J; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Vasan N; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Lin TY; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Orozco JM; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Schoenherr C; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Sagum C; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Bedford MT; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Wynn RM; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Tso SC; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Chuang DT; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Li L; Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, USA.
  • Li SS; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Creixell P; Department of Discovery Technologies, Calico Life Sciences, South San Francisco, CA, USA.
  • Krismer K; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
  • Takegami M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Lee H; Cancer Research United Kingdom Scotland Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
  • Zhang B; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lu J; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cossentino I; Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Landry SD; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Uduman M; Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Blenis J; Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Elemento O; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Frame MC; School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao, China.
  • Hornbeck PV; Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Canada.
  • Cantley LC; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Turk BE; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Yaffe MB; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Johnson JL; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nature ; 629(8014): 1174-1181, 2024 May.
Article en En | MEDLINE | ID: mdl-38720073
ABSTRACT
Phosphorylation of proteins on tyrosine (Tyr) residues evolved in metazoan organisms as a mechanism of coordinating tissue growth1. Multicellular eukaryotes typically have more than 50 distinct protein Tyr kinases that catalyse the phosphorylation of thousands of Tyr residues throughout the proteome1-3. How a given Tyr kinase can phosphorylate a specific subset of proteins at unique Tyr sites is only partially understood4-7. Here we used combinatorial peptide arrays to profile the substrate sequence specificity of all human Tyr kinases. Globally, the Tyr kinases demonstrate considerable diversity in optimal patterns of residues surrounding the site of phosphorylation, revealing the functional organization of the human Tyr kinome by substrate motif preference. Using this information, Tyr kinases that are most compatible with phosphorylating any Tyr site can be identified. Analysis of mass spectrometry phosphoproteomic datasets using this compendium of kinase specificities accurately identifies specific Tyr kinases that are dysregulated in cells after stimulation with growth factors, treatment with anti-cancer drugs or expression of oncogenic variants. Furthermore, the topology of known Tyr signalling networks naturally emerged from a comparison of the sequence specificities of the Tyr kinases and the SH2 phosphotyrosine (pTyr)-binding domains. Finally we show that the intrinsic substrate specificity of Tyr kinases has remained fundamentally unchanged from worms to humans, suggesting that the fidelity between Tyr kinases and their protein substrate sequences has been maintained across hundreds of millions of years of evolution.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Especificidad por Sustrato / Tirosina / Proteínas Tirosina Quinasas / Fosfotirosina Límite: Animals / Humans Idioma: En Revista: Nature Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Especificidad por Sustrato / Tirosina / Proteínas Tirosina Quinasas / Fosfotirosina Límite: Animals / Humans Idioma: En Revista: Nature Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos